Compounded semaglutide
Sold by RestorLife Med · every compounded semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$56
| Medication · GLP-1 Microdose, 3 month (list $113/mo) | $56 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| GLP-1 Protocol, 3 month (list $299/mo) “3 month $209 $299 /mo” | Per month$209 | Charged today$627 |
| GLP-1 Microdose, 3 month (list $113/mo) “3 month $56 $113 /mo” | Per month$56 | Charged today$168 |
| GLP-1 Protocol, 6 month (list $299/mo) “6 month $199 $299 /mo” | Per month$199 | Charged today$1,194 |
We earn nothing from this link. RestorLife Med has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | All 50 states |
|---|---|
| Prescriber | Both |
| Cancellation | “Can I cancel anytime? Yes. There are no long-term contracts or commitments. You can pause or cancel your membership at any time through your patient portal or by contacting our support team.” |
Not yet checked: pharmacy, membership and consult fee.
Recorded from restorlifemed.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Prices are for a first-order-discounted rate shown beside a crossed-out list price (e.g. '$149 $219/mo'); both numbers were captured, with perMonth set to the actual advertised price and the list price kept in each quote. In addition to the standard-dose semaglutide/tirzepatide protocols, the site sells 'microdose' tiers of each drug at lower doses/prices, recorded as separate price entries under the same drug. The homepage names the physician as 'Licensed in all 50 states,' but that describes the physician's individual licensure, not a company-wide service-area claim — the site's own Terms of Service instead says only 'certain states' are served with no list, so states was recorded as not-found rather than all-50. RestorLife Med's telemedicine consent is issued by 'Beluga Health, P.A.' — the same Beluga Health checked separately in this batch as a B2B infrastructure vendor.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.